22-37691327-C-G

Variant names:

• chr22-37691327-C-G
• rs1008331470
• NM_024313.3:c.633C>G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2 BP4_Moderate

The NM_024313.3(NOL12):​c.633C>G​(p.Ser211Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: NOL12 NM_024313.3 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: -0.912

Genes affected

NOL12 (HGNC:28585): (nucleolar protein 12) Enables identical protein binding activity. Predicted to be active in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]

ENSG00000100101 (HGNC:):

ACMG classification

Verdict is Uncertain_significance. Variant got 0 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.08297598).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
NOL12	NM_024313.3	c.633C>G	p.Ser211Arg	missense_variant	Exon 6 of 6	ENST00000359114.9	NP_077289.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
NOL12	ENST00000359114.9	c.633C>G	p.Ser211Arg	missense_variant	Exon 6 of 6	1	NM_024313.3	ENSP00000352021.4
ENSG00000100101	ENST00000455236.4	n.612C>G		non_coding_transcript_exon_variant	Exon 6 of 13	5		ENSP00000477208.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

not specified Uncertain:1

Mar 21, 2022

Ambry Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.633C>G (p.S211R) alteration is located in exon 6 (coding exon 6) of the NOL12 gene. This alteration results from a C to G substitution at nucleotide position 633, causing the serine (S) at amino acid position 211 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.15
BayesDel_addAF	Benign	-0.075	T
BayesDel_noAF	Benign	-0.35
CADD	Benign	0.25
DANN	Benign	0.95
DEOGEN2	Benign	0.073	T;T
Eigen	Benign	-1.4
Eigen_PC	Benign	-1.4
FATHMM_MKL	Benign	0.068	N
LIST_S2	Benign	0.62	.;T
M_CAP	Benign	0.052	D
MetaRNN	Benign	0.083	T;T
MetaSVM	Benign	-0.82	T
MutationAssessor	Benign	1.0	L;L
PrimateAI	Benign	0.36	T
PROVEAN	Benign	0.22	N;.
REVEL	Benign	0.13
Sift	Benign	0.089	T;.
Sift4G	Benign	0.23	T;T
Polyphen		0.11	B;B
Vest4		0.19
MutPred		0.32		Loss of phosphorylation at S211 (P = 0.0013);Loss of phosphorylation at S211 (P = 0.0013);
MVP		0.58
MPC		0.46
ClinPred		0.20	T
GERP RS		-5.9
Varity_R		0.037
gMVP		0.053

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.040		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1008331470; hg19: chr22-38087334;